5-Bromo-2-chlorobenzoic Acid: A Key Pharmaceutical Intermediate for Diabetes Treatment
Essential for producing vital diabetes medications, this fine chemical empowers pharmaceutical innovation.
Get a Quote & SampleProduct Core Value
5-Bromo-2-chlorobenzoic acid
This compound is a critical building block in the synthesis of Dapagliflozin, a vital medication for managing type 2 diabetes. Its precise chemical structure and high purity ensure the efficacy and safety of the final pharmaceutical product.
- This compound plays a crucial role in the buy 5-Bromo-2-chlorobenzoic acid China supply chain for pharmaceutical manufacturing.
- Leveraging 5-Bromo-2-chlorobenzoic acid for dapagliflozin synthesis supports the global fight against type 2 diabetes.
- As a key pharmaceutical intermediate, its quality directly impacts drug efficacy, making CAS 21739-92-4 a vital chemical.
- The organic synthesis applications of this compound are expanding due to its utility in creating complex therapeutic molecules.
Key Advantages
Purity and Quality
Ensuring 99.5% MIN assay, this compound adheres to USP, BP, EP, and FCC standards, vital for pharmaceutical applications.
Therapeutic Impact
Its use in 5-Bromo-2-chlorobenzoic acid for dapagliflozin synthesis directly benefits patients managing type 2 diabetes.
Synthetic Versatility
As a fine chemical, it offers broad applications in various organic synthesis pathways beyond its primary pharmaceutical use.
Key Applications
Pharmaceutical Synthesis
Crucial for the production of selective sodium-glucose cotransporter 2 inhibitors, essential for treating type 2 diabetes patients.
Drug Manufacturing
A key intermediate utilized by pharmaceutical manufacturers to develop and produce life-saving medications, supporting the buy 5-Bromo-2-chlorobenzoic acid China market dynamics.
Organic Chemistry
Serves as a versatile building block for complex organic molecules, enabling advancements in chemical research and development using CAS 21739-92-4.
API Production
Contributes to the synthesis of Active Pharmaceutical Ingredients (APIs), particularly those targeting metabolic disorders.